GlassScriptPhysician profile
Eitan M Kohan
NPI 1619358207
$72,871.37
in general payments reported to CMS, 2019-2025
27 companies · $43K in 2025
The $43K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,990 · 2020: $128 · 2021: $11K · 2022: $1,608 · 2023: $3,598 · 2024: $11K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $42K · Travel and Lodging: $10K · Food and Beverage: $5,107 · Gift: $98.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $42,450.00 |
| Travel and Lodging | $10,346.88 |
| Food and Beverage | $5,106.78 |
| Gift | $98.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $53,943.07 | 2022-2025 | Inset System |
| Arthrex, INC. | $3,559.97 | 2021-2024 | |
| Encore Medical, LP | $3,450.69 | 2020-2023 | Djo Surgical |
| Seapearl East, INC | $2,004.50 | 2021-2025 | |
| Stryker Corporation | $1,695.83 | 2021-2025 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Augmented Glenoid, Aequalis Ascend Flex |
| Elite Orthopedics, LLC | $1,497.00 | 2019 | |
| Globus Medical, INC. | $1,397.48 | 2021-2024 | Distal Radius II, Proximal Humerus Strut, Clavicular Fracture Fixation |
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Zimmer Biomet Holdings, INC. | $975.05 | 2021-2025 | Comprehensive, Comprehensive Shoulder System |
| Tigon Medical LLC | $919.00 | 2025 | |
| Depuy Synthes Sales INC. | $462.47 | 2019-2025 | Fms, Vapr, Healix Knotless Peek |
| Zurimed Technologies INC. | $317.29 | 2025 | Fiberlocker System |
| Medical Device Business Services, INC. | $299.99 | 2019 | |
| Catalyst Orthoscience | $178.83 | 2023-2024 | R1 Reverse Shoulder System, Catalyst Csr Shoulder System, R1 Reverse Total Shoulder |
| Skeletal Dynamics INC | $145.00 | 2024 | Align, Implate, Geminus |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $136.52 | 2021 | |
| Exactech, INC. | $135.84 | 2021 | |
| Medacta USA, INC. | $119.86 | 2019 | |
| Mvp Orthopedics INC | $89.13 | 2021 | |
| Kerecis Limited | $81.98 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Bioventus LLC | $73.67 | 2024-2025 | Durolane, Xcell |
| Wright Medical Technology, INC. | $49.82 | 2019 | |
| Axogen | $38.61 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $37.30 | 2022-2025 | Iovera |
| Acera Surgical, INC. | $29.51 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $19.96 | 2021 | |
| Biedermann Motech, INC. | $13.00 | 2023 | Proximal Humerus Plating System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eitan Kohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.